KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

F5 (FFIV) Receivables (2016 - 2025)

F5 (FFIV) has disclosed Receivables for 17 consecutive years, with $531.7 million as the latest value for Q4 2025.

  • Quarterly Receivables fell 42.14% to $531.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $531.7 million through Dec 2025, down 42.14% year-over-year, with the annual reading at $912.7 million for FY2025, 116.44% up from the prior year.
  • Receivables hit $531.7 million in Q4 2025 for F5, down from $912.7 million in the prior quarter.
  • In the past five years, Receivables ranged from a high of $918.9 million in Q4 2024 to a low of $413.5 million in Q1 2025.
  • Historically, Receivables has averaged $633.5 million across 5 years, with a median of $588.1 million in 2021.
  • Biggest YoY gain for Receivables was 116.44% in 2025; the steepest drop was 46.17% in 2025.
  • Year by year, Receivables stood at $454.0 million in 2021, then grew by 14.35% to $519.1 million in 2022, then rose by 4.81% to $544.1 million in 2023, then skyrocketed by 68.89% to $918.9 million in 2024, then crashed by 42.14% to $531.7 million in 2025.
  • Business Quant data shows Receivables for FFIV at $531.7 million in Q4 2025, $912.7 million in Q3 2025, and $820.0 million in Q2 2025.